Medical Condition

sarcoma

Total Trials

20

Recruiting Now

20

Trial Phases

Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for sarcoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — sarcoma Clinical Trials

How many clinical trials are currently recruiting for sarcoma?

ClinicalMetric currently tracks 20 actively recruiting clinical trials for sarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 20. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for sarcoma?

sarcoma research spans Phase 1 (4 trials), Phase 2 (6 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a sarcoma clinical trial?

Eligibility criteria for sarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University 1 trial

Dana-Farber Cancer Institute 1 trial

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1 trial

Sheffield Teaching Hospitals NHS Foundation Trust 1 trial

National Cancer Institute (NCI) 1 trial

sarcoma

Frequently Asked Questions — sarcoma Clinical Trials

Recruiting Clinical Trials

Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)

Video Education With Result Dependent dIsclosure

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Ex VIvo DEtermiNed Cancer Therapy

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Establishment of a Prospective Clinical-biological Database

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing Surgical Treatment: Observational Study

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

Ivonescimab in the Treatment of Multiple Advanced Tumors

Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group